
About the Department
The US-based Emerging Obesity Mechanisms department delivers scientific excellence in energy‑expenditure‑, muscle‑, and liver‑related mechanisms of obesity, advancing novel small‑molecule and RNAi targets through human in vitro characterization and mode‑of‑action discovery. As part of Obesity Research US, it helps diversify the pipeline, contributing to the broader Obesity & Cardiometabolic Research goal of building a differentiated pipeline across obesity and its comorbidities.
The Position
Are you a driven and passionate scientist with a strong scientific background in Obesity related comorbidities, such as MASH or CVD? Do you wish to help shape our research initiatives and contribute to the development of life-changing therapies? Look no further! Our company is seeking a highly motivated Principal Scientist to join our Emerging Obesity Mechanisms research team as part of the US Obesity Research Department.
As a Principal Scientist, you will be responsible for executing and delivering on our Obesity and Cardiometabolic Comorbidities portfolio and be considered a disease expert. You will be involved in leading and championing target data packages from discovery through IND submissions for our US-based Obesity Research department.
Relationships
Reports to the Director of Emerging Obesity Mechanisms at Novo Nordisk in Massachusetts. Internal relationships include working closely with technical staff & other members of the Obesity Research US leadership team. Additionally, regular collaborations with members of other research departments & frequent interaction with project managers, project leads, governance leadership, and other colleagues across global R&D. Individual may indirectly mentor less experienced team members. Individuals may interact with external research collaborators in both academia and industry.
Essential Functions
Qualifications
The base compensation range for this position is $180,000 to $235,000. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance. Novo Nordisk offers long-term incentive compensation and or company vehicles depending on the position's level or other company factors.
Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy, and parental leave policy.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and defeating diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.
Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.
If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html